Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-19-000337

Director sold 96,743 shares at $10.01 ($968,397)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
TREU JESSE I Director 2019-03-26 Sale −96,298 $10.01 $963,943 1,877,091 I
TREU JESSE I Director 2019-03-26 Sale −445 $10.01 $4,454 8,763 I
Open-market sales · 96,743 sh · avg $10.01 · $968,397
Loading xslF345X03/edgar.xml…